An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment

Archives of General Psychiatry

Volumn 68, Issue 6, 2011, Pages 577-584

  Watkins, Katherine E ^a   Hunter, Sarah B ^a   Hepner, Kimberly A ^a   Paddock, Susan M ^a   De La Cruz, Erin ^a   Zhou, Annie J ^a   Gilmore, Jim ^b  

^a RAND CORPORATION   (United States)

^b Behavioral Health Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL ABUSE; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PSYCHOLOGIC ASSESSMENT; QUASI EXPERIMENTAL STUDY; SHORT FORM 12; SUBSTANCE ABUSE; THERAPY EFFECT; TREATMENT OUTCOME; UNITED STATES;

ADULT; ALCOHOL DRINKING; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PSYCHOTHERAPY, GROUP; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 79958060186     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.53     Document Type: Article

References (59)

1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. (Pubitemid 39031120)
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. (Pubitemid 40973434)
3. Murray CJ, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Disease, Injuries, and Risk Factors, in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health, on behalf of the WHO and the World Bank; 1996.
4. Clark HW, Power AK, Le Fauve CE, Lopez EI. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat. 2008;34(1):3-13. (Pubitemid 350225649)
5. Boden MT, Moos R. Dually diagnosed patients' responses to substance use disorder treatment. J Subst Abuse Treat. 2009;37(4):335-345.
6. Grella CE, Stein JA. Impact of program services on treatment outcomes of patients with comorbidmental and substance use disorders. Psychiatr Serv. 2006;57(7):1007-1015. (Pubitemid 44036232)
7. Burnam MA, Watkins KE. Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff (Millwood). 2006;25(3):648-658. (Pubitemid 43824914)
8. Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: issues and prospects. J Subst Abuse Treat. 2008;34(1):36-47. (Pubitemid 350216354)
9. Muñoz RF, Mendelson T. Toward evidence-based interventions for diverse populations: the San Francisco General Hospital prevention and treatment manuals. J Consult Clin Psychol. 2005;73(5):790-799. (Pubitemid 41643229)
10. Oei TP, Dingle G. The effectiveness of group cognitive behaviour therapy for unipolar depressive disorders. J Affect Disord. 2008;107(1-3):5-21. (Pubitemid 351288904)
11. Hohmann AA, Shear MK. Community-based intervention research: coping with the "noise" of real life in study design. Am J Psychiatry. 2002;159(2):201-207.
12. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737-1744. (Pubitemid 29533604)
13. Beck A, Steer R, Brown G. BDI-II, Beck Depression Inventory: Manual. 2nd ed. Boston, MA: Harcourt Brace; 1996.
14. Buckley TC, Parker JD, Heggie J. A psychometric evaluation of the BDI-II in treatment- seeking substance abusers. J Subst Abuse Treat. 2001;20(3):197-204. (Pubitemid 32552040)
15. Sloan KL, Kivlahan D, Saxon AJ. Detecting bipolar disorder among treatment-seeking substance abusers. Am J Drug Alcohol Abuse. 2000;26(1):13-23. (Pubitemid 30127423)
16. Dennis ML, White MK, Titus JC, Unsicker JI. Short Blessed Scale Exam: Global Appraisal of Individual Needs: Trainer's Training Manual and Resources. July 2006 version. Bloomington, IL: Chestnut Health Systems; 2006.
17. Walters E, Kessler R, Nelson C, Mroczek D. Composite International Diagnostic Interview (CIDI) 2.1. Geneva, Switzerland: World Health Organization; 1998.
18. McLellan A, Carise D, Coyne T. Addiction Severity Index (ASI). 5th ed. Philadelphia, PA: Treatment Research Institute; 2005.
19. Sobell LC, Sobell MB. Alcohol Timeline Followback Users' Manual. Toronto, ON, Canada: Addiction Research Foundation; 1995.
20. Alterman AI, McDermott PA, Cook TD, Metzgera D, Rutherford MJ, Cacciola JS, Lawrence S, Brown J. New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent. Psychol Addict Behav. 1998;12(4):233-246. (Pubitemid 28565865)
21. Fals-Stewart W, O'Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol. 2000;68(1):134-144. (Pubitemid 30120958)
22. Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers' self-reports of drinking behavior. Behav Res Ther. 1979;17(2):157-160. (Pubitemid 9128763)
23. Sobell LC, Sobell MB. Validity of self-reports in three populations of alcoholics. J Consult Clin Psychol. 1978;46(5):901-907. (Pubitemid 9038988)
24. Sobell LC, Sobell MB. Convergent validity: an approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. In: Sobell LC, Sobell MB, Ward E, eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York, NY: Pergamon Press; 1980.
25. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. (Pubitemid 126433231)
26. Lewinsohn P, Mũnoz R, Youngren M, Zeiss A. Control Your Depression. New York, NY: Prentice Hall Press; 1986.
27. Muñoz R, Ippen C, Rao S, Le H, Dwyer E. Manual for Group Cognitive-Behavioral Therapy of Major Depression: A Reality Management Approach. San Francisco: San Francisco General Hospital, University of California; 2000.
28. Miller WR, Rollnick S. Motivational Interviewing. New York, NY: Guilford; 1991.
29. Stark MJ, Kane BJ. General and specific psychotherapy role induction with substance- abusing clients. Int J Addict. 1985;20(8):1135-1141. (Pubitemid 16213144)
30. Drapkin ML, Tate SR, McQuaid JR, Brown SA. Does initial treatment focus influence outcomes for depressed substance abusers? J Subst Abuse Treat. 2008;35(3):343-350.
31. Barber JP, Liese B, Abrams MJ. Development of the Cognitive Therapy Adherence and Competence Scale. Psychother Res. 2003;13(2):205-221. (Pubitemid 40990853)
32. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46(5):423-429. (Pubitemid 23194263)
33. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. (Pubitemid 8054849)
34. Lehman WE, Greener JM, Simpson DD. Assessing organizational readiness for change. J Subst Abuse Treat. 2002;22(4):197-209. (Pubitemid 34606038)
35. Simpson D. Organizational readiness for stage-based dynamics of innovation implementation. Res Soc Work Pract. 2009;19(5):541-551.
36. Hunter SB. Group CBT for depression in substance abuse treatment: how does it work? Paper presented at: International Conference on the Treatment of Addictive Behaviors; 2010; Santa Fe, NM.
37. Browne WJ, Goldstein H, Rasbash J. Multiple membership multiple classification (MMMC) models. Stat Modelling. 2001;1(2):103-124.
38. Carey K. Amultilevel modelling approach to analysis of patient costs under managed care. Health Econ. 2000;9(5):435-446. (Pubitemid 30612146)
39. Fitzmaurice G, Laird NM, Ware J. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons; 2004.
40. Weisberg S. Applied Linear Regression. 3rd ed. Hoboken, NJ: Wiley/ Interscience; 2005.
41. Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use among individuals with alcohol use disorders. J Subst Abuse Treat. 2009;37(2):127-137.
42. Brown RA, Evans DM, Miller IW, Burgess ES, Mueller TI. Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol. 1997;65(5):715-726. (Pubitemid 27439063)
43. Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone: a systematic review of the published literature. BMC Psychiatry. 2009;9(1):6. doi:10.1186/1471-244X-9-6.
44. Markowitz JC, Kocsis JH, Christos P, Bleiberg K, Carlin A. Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. J Nerv Ment Dis. 2008;196(6):468-474.
45. Tiet QQ, Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res. 2007;31(4):513-536. (Pubitemid 46434889)
46. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. (Pubitemid 41396935)
47. Grant BF. The influence of comorbid major depression and substance use disorder on alcohol and drug treatment: results of a national survey. NIDA Res Monogr Ser. 1997;172:4-15.
48. Burns L, Teesson M. Alcohol use disorders comorbid with anxiety, depression and drug use disorders: findings from the Australian National Survey of Mental Health and Well Being. Drug Alcohol Depend. 2002;68(3):299-307. (Pubitemid 35232565)
49. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380. (Pubitemid 34275256)
50. Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry. 2004;65(6):810-819.
51. Watkins KE, Paddock SM, Zhang L, Wells KB. Improving care for depression in patients with comorbid substance misuse. Am J Psychiatry. 2006;163(1):125-132. (Pubitemid 43050113)
52. Ducharme LJ, Knudsen HK, Roman PM. Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J. 2006;42(4):363-375. (Pubitemid 44369241)
53. Gil-Rivas V, Grella CE. Treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuse providers. Community Ment Health J. 2005;41(3):251-266. (Pubitemid 40933549)
54. Watkins KE, Burnam A, Kung FY, Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv. 2001;52(8):1062-1068. (Pubitemid 32757998)
55. Grella CE, Gil-Rivas V, Cooper L. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. J Behav Health Serv Res. 2004;31(1):38-49. (Pubitemid 39060783)
56. Brown J, Kranzler HR, Del Boca FK. Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. Br J Addict. 1992;87(7):1013-1024.
57. Rush AJ, Carmody TJ, Ibrahim HM, Trivedi MH, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM. Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv. 2006;57(6):829-837. (Pubitemid 43846295)
58. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry. 1998;155(1):127-128. (Pubitemid 28037561)
59. Zimmerman M, Coryell W, Wilson S, Corenthal C. Evaluation of symptoms of major depressive disorder: self-report vs. clinician ratings. J Nerv Ment Dis. 1986;174(3):150-153. (Pubitemid 16117405)